Vaccination against atherosclerosis: An overview
Open Access
- 1 March 2020
- journal article
- review article
- Published by Elsevier in Hellenic Journal of Cardiology
- Vol. 61 (2) , 78-91
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesionsJournal of Autoimmunity, 2012
- Immune Response to Lipoproteins in AtherosclerosisCholesterol, 2012
- The autoimmune concept of atherosclerosisCurrent Opinion in Lipidology, 2011
- Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureusJournal of Biological Chemistry, 2009
- Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase–positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteinsClinical and Experimental Immunology, 2007
- A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicityJournal Of Hypertension, 2007
- Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (−/−) miceBiochemical and Biophysical Research Communications, 2005
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Proceedings of the National Academy of Sciences, 2005
- Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesionsBiochemical and Biophysical Research Communications, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003